Leap Therapeutics
LPTX
LPTX
42 hedge funds and large institutions have $10.6M invested in Leap Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
34.29% less ownership
Funds ownership: 64.57% → 30.28% (-34%)
56% less capital invested
Capital invested by funds: $24.1M → $10.6M (-$13.5M)
Holders
42
Holding in Top 10
–
Calls
$36K
Puts
$5K
Top Buyers
| 1 | +$772K | |
| 2 | +$489K | |
| 3 | +$489K | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$423K |
| 5 |
6CM
683 Capital Management
New York
|
+$255K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$748K | |
| 3 | -$569K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$93.4K |
| 5 |
DMKJ
David M. Knott Jr
|
-$90K |